{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:54:15Z","timestamp":1784876055561,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"am","delay-in-days":285,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bone.2023.116819","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T02:36:37Z","timestamp":1686191797000},"page":"116819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Denosumab use in bone fibrous dysplasia refractory to bisphosphonate: A retrospective multicentric study"],"prefix":"10.1016","volume":"174","author":[{"given":"M.C.","family":"Trojani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gensburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bagouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Cortet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Couture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Marcelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mehsen Cetre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Breuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Chapurlat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2023.116819_bb0005","article-title":"Best practice management guidelines for fibrous dysplasia\/McCune-Albright syndrome: a consensus statement from the FD\/MAS international consortium","volume":"14","author":"Javaid","year":"2019","journal-title":"Orphanet. J. Rare Dis. [Internet]"},{"issue":"2","key":"10.1016\/j.bone.2023.116819_bb0010","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jbmr.3602","article-title":"Activation of RANK\/RANKL\/OPG pathway is involved in the pathophysiology of fibrous dysplasia and associated with disease burden","volume":"34","author":"de Castro","year":"2019","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2023.116819_bb0015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00223-019-00550-z","article-title":"Fibrous dysplasia of bone and McCune-Albright syndrome: a bench to bedside review","volume":"104","author":"Hartley","year":"2019","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"10.1016\/j.bone.2023.116819_bb0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/berh.1999.0071","article-title":"Fibrous dysplasia of bone","volume":"14","author":"Chapurlat","year":"2000","journal-title":"Baillieres Best Pract. Res. Clin. Rheumatol."},{"issue":"11","key":"10.1016\/j.bone.2023.116819_bb0025","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa091","article-title":"Denosumab for fibrous dysplasia: promising, but questions remain","volume":"105","author":"Collins","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"49","key":"10.1016\/j.bone.2023.116819_bb0030","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000028138","article-title":"Successful treatment with denosumab for pelvic fibrous dysplasia","volume":"100","author":"Ikuta","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.bone.2023.116819_bb0035","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jbmr.1603","article-title":"Denosumab treatment for fibrous dysplasia","volume":"27","author":"Boyce","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.bone.2023.116819_bb0040","doi-asserted-by":"crossref","first-page":"e2980","DOI":"10.1210\/clinem\/dgab212","article-title":"Denosumab reduces lesional fluoride skeletal burden on Na[18F]F PET-CT in patients with fibrous dysplasia\/McCune\u2013Albright syndrome","volume":"106","author":"van der Bruggen","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.bone.2023.116819_bb0045","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.4380","article-title":"Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study","volume":"36","author":"Meier","year":"2021","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.bone.2023.116819_bb0050","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00198-021-05895-6","article-title":"Denosumab for craniofacial fibrous dysplasia: duration of efficacy and post-treatment effects","volume":"32","author":"Raborn","year":"2021","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.bone.2023.116819_bb0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jbspin.2020.03.007","article-title":"A case of recalcitrant fibrous dysplasia treated with denosumab","volume":"87","author":"Gautam","year":"2020","journal-title":"Joint Bone Spine."},{"issue":"3","key":"10.1016\/j.bone.2023.116819_bb0060","first-page":"253","article-title":"Prompt clinical and biochemical response to denosumab in a young adult patient with craniofacial fibrous dysplasia","volume":"13","author":"Eller-Vainicher","year":"2016","journal-title":"Clin. Cases Miner. Bone Metab."},{"issue":"6","key":"10.1016\/j.bone.2023.116819_bb0065","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jbspin.2014.04.013","article-title":"Transient improvement of severe pain from fibrous dysplasia of bone with denosumab treatment","volume":"81","author":"Benhamou","year":"2014","journal-title":"Joint Bone Spine."},{"issue":"2","key":"10.1016\/j.bone.2023.116819_bb0070","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00198-013-2585-1","article-title":"Rapid biochemical response to denosumab in fibrous dysplasia of bone: report of two cases","volume":"25","author":"Ganda","year":"2014","journal-title":"Osteoporos Int. J. Establ. Result Coop. Eur. Found Osteoporos Natl. Osteoporos. Found USA"},{"issue":"1","key":"10.1016\/j.bone.2023.116819_bb0075","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.eprac.2022.07.012","article-title":"Denosumab use in adults with fibrous dysplasia: case reports and review of the literature","volume":"28","author":"Hung","year":"2022","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.bone.2023.116819_bb0080","article-title":"Regression of fibrous dysplasia in response to denosumab therapy: a report of two cases","volume":"14","author":"Meier","year":"2021","journal-title":"Bone Rep."},{"issue":"6","key":"10.1016\/j.bone.2023.116819_bb0085","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00223-020-00752-w","article-title":"Zoledronic acid in a mouse model of human fibrous dysplasia: ineffectiveness on tissue pathology, formation of \u2018giant osteoclasts\u2019 and pathogenetic implications","volume":"107","author":"Corsi","year":"2020","journal-title":"Calcif. Tissue Int."},{"issue":"12","key":"10.1016\/j.bone.2023.116819_bb0090","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1210\/jc.2018-02543","article-title":"Denosumab in patients with fibrous dysplasia previously treated with bisphosphonates","volume":"104","author":"Majoor","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.bone.2023.116819_bb0095","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1002\/jbmr.3828","article-title":"RANKL inhibition in fibrous dysplasia of bone: a preclinical study in a mouse model of the human disease","volume":"34","author":"Palmisano","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.bone.2023.116819_bb0100","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1056\/NEJMc2214862","article-title":"Safety and efficacy of denosumab for fibrous dysplasia of bone","volume":"388","author":"de Castro","year":"2023","journal-title":"N. Engl. J. Med."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328223001527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328223001527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:04:33Z","timestamp":1757613873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328223001527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":20,"alternative-id":["S8756328223001527"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2023.116819","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Denosumab use in bone fibrous dysplasia refractory to bisphosphonate: A retrospective multicentric study","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2023.116819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116819"}}